bluebird bio Inc.

NASDAQ: BLUE · Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM

bluebird bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
103.95M 83.81M 53.12M 54.9M 45.69M 29.5M 21.73M 9.4M 4.03M 3.6M 5.14M 27.75M 33.7M 44.55M 53.65M 50.25M 241.66M
Cost of Revenue
75.75M 89.38M 76.22M 75.4M 56.02M 33.53M 23.92M 14.35M 6.53M 11.46M 15.12M 33.44M 57.07M 51.04M 48.86M 30.47M 6.65M
Gross Profit
28.19M -5.57M -23.1M -20.5M -10.33M -4.03M -2.19M -4.95M -2.5M -7.87M -9.98M -5.69M -23.37M -6.49M 4.79M 19.78M 235.01M
Operating Income
-216.38M -270.46M -316.68M -334.49M -331.39M -244.26M -136.15M -137.91M -160.01M -288.79M -449.89M -580.37M -713.8M -824.67M -892.98M -865.72M -650.83M
Interest Income
6.25M 8.22M 8.96M 9.78M 9.62M 9.87M 8.33M 6.26M 3.75M 1.03M 809K 586K 630K 879K 2.01M 3.82M 6.54M
Pretax Income
-199.81M -240.65M -300.6M -311.47M -303.08M -212.04M -91.14M -95.92M -123.07M -266.46M -431.04M -571.46M -712.8M -796.39M -863.78M -841.26M -621.23M
Net Income
-199.98M -240.72M -300.52M -311.44M -302.96M -199.11M -78.36M -83.15M -103.12M -261.12M -448.41M -588.7M -737.53M -819.38M -864.2M -842.13M -621.89M
Selling & General & Admin
151.81M 167.87M 183.58M 184.52M 174.49M 165.51M 149.11M 141.81M 138.16M 136.91M 159.41M 194.28M 236.16M 286.93M 310.7M 310.47M 300.52M
Research & Development
86.9M 94.25M 107.18M 129.47M 146.58M 167.65M 179.78M 187.47M 209.03M 240.76M 274.25M 352.53M 433M 509.6M 567.31M 576.32M 588.31M
Other Expenses
-49K -49K n/a n/a n/a n/a -102M -94.11M -94.11M -94.11M 7.88M -294K -1.38M -1.38M -1.38M -1.09M 1.55M
Operating Expenses
238.66M 262.08M 290.76M 313.99M 321.06M 333.16M 226.89M 227.28M 245.19M 275.67M 433.66M 546.81M 669.17M 796.54M 878.01M 886.79M 888.83M
Interest Expense
22.68M 21.79M 20.11M 14.33M 12.63M 12.04M 8.02M 8.02M 4.27M n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
314.41M 351.46M 366.99M 389.39M 377.08M 366.69M 250.81M 240.24M 250.33M 285.75M 447.39M 580.25M 726.23M 847.58M 926.87M 917.26M 895.49M
Income Tax Expense
86K 186K 33K -25K -126K -12.93M -12.77M -12.77M -19.95M -5.34M -5.36M -5.48M 2M 258K 422K 864K 658K
Shares Outstanding (Basic)
9.75M 64.11M 64.11M 64.11M 64.11M 71.35M 71.35M 71.35M 71.35M 85.18M 81.4M 73.63M 73.69M 72.5M 68.54M 67.49M 66.98M
Shares Outstanding (Diluted)
9.75M 64.11M 64.11M 64.11M 64.11M 71.35M 71.35M 71.35M 71.35M 85.18M 81.54M 73.77M 73.69M 72.5M 68.62M 67.49M 66.98M
EPS (Basic)
-5.65 -3.76 -4.55 -4.61 -4.36 -2.94 -1.32 -1.25 -1.49 -3.5 -6.02 -8.24 -10.56 -11.95 -12.82 -12.6 -9.38
EPS (Diluted)
-5.65 -3.76 -4.55 -4.61 -4.36 -2.79 -1.17 -1.1 -1.34 -3.5 -6.02 -8.24 -10.56 -11.95 -12.82 -12.6 -9.38
EBITDA
-132.74M -157.61M -128.23M -173.22M -179.46M -107.66M -101.36M -101.72M -135.5M -277.15M -437.51M -480.71M -530M -551.4M -612.38M -669.66M -544M
EBIT
-153.91M -218.86M -230.05M -259.69M -242.89M -156.71M -97.17M -98.92M -140.57M -282.15M -208.96M -256.75M -310.69M -336.44M -634.69M -690.94M -563.84M
Depreciation & Amortization
45.77M 61.24M 72.74M 58.47M 42.91M 28.52M 4.38M 4.7M 5.07M 5M 6.06M 10.65M 15.3M 19.65M 22.31M 21.28M 19.84M